Placeholder Banner

BIO Statement for House Financial Services Subcommittee on Capital Markets Hearing: “A Roadmap for Growth: Reforms to Encourage Capital Formation and Investment Opportunities for All Americans”

April 23, 2023

BIO’s Chief Advocacy Officer Nick Shipley presents comments to the Committee as it considers reforms to encourage capital formation and investment opportunities for all Americans.

Download Full Comments Below
BIO HFSC Statement for the Record on Capital Formation
Discover More
In these comments, BIO addresses FDA’s four specific topic areas of consideration as the agency develops its draft guidance per PDUFA VII.
BIO joined with more than 40 groups in calling on Congress to set 2024 funding for the U.S. Codex Office at or above the 2023 level. 
BIO’s comments support accelerated approval as an important regulatory pathway that allows patients with serious and life-threatening illnesses such as cancer to have earlier access to promising therapies.